1-(3-(2,6-dioxopiperazin-1-yl)propyl)piperazine-2,6-dione

ID: ALA4065194

PubChem CID: 137632573

Max Phase: Preclinical

Molecular Formula: C11H16N4O4

Molecular Weight: 268.27

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1CNCC(=O)N1CCCN1C(=O)CNCC1=O

Standard InChI:  InChI=1S/C11H16N4O4/c16-8-4-12-5-9(17)14(8)2-1-3-15-10(18)6-13-7-11(15)19/h12-13H,1-7H2

Standard InChI Key:  WRCQIEUAHHKKLN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   32.8123  -20.2156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1029  -20.6212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0994  -21.4339    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8037  -21.8471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5131  -21.4416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5183  -20.6227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8139  -19.3984    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.2187  -21.8539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.2232  -20.2149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9313  -20.6229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6386  -20.2137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3467  -20.6216    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.3453  -21.4358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0493  -21.8436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7590  -21.4379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.7602  -20.6197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0517  -20.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6369  -21.8432    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.0500  -19.3901    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  7  2  0
  5  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 13 18  2  0
 17 19  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4065194

    ---

Associated Targets(Human)

NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 268.27Molecular Weight (Monoisotopic): 268.1172AlogP: -2.71#Rotatable Bonds: 4
Polar Surface Area: 98.82Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: -3.33CX LogD: -3.33
Aromatic Rings: Heavy Atoms: 19QED Weighted: 0.54Np Likeness Score: -0.54

References

1. Kumar A, Banerjee S, Roy P, Sondhi SM, Sharma A..  (2017)  Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity.,  27  (3): [PMID:28011220] [10.1016/j.bmcl.2016.12.031]

Source